To access this element change to forms mode OFF
Grant Award View - GA294523
Reducing Cognitive impairment by management of Heart Failure as a...
GA ID:
GA294523
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
13-Feb-2023
Publish Date:
11-Apr-2023
Category:
Medical Research
Grant Term:
1-Apr-2023 to 31-Mar-2026
Value (AUD):
$549,436.14
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
International Joint Calls
Grant Activity:
Reducing Cognitive impairment by management of Heart Failure as a Modifiable Risk Factor: the Cog-HF trial
Purpose:
This study will test the feasibility and effectiveness of an innovative model of care for cognitively impaired patients with heart failure. The program aims to improve cognition, reduce dementia risk and cardiovascular events, and will be supported by innovative technology for wide scale rollout and implementation. These findings will transform the way healthcare is delivered to cognitively-impaired patients with heart disease, and substantially reduce dementia in Australia and Japan.
GO ID:
GO Title:
NHMRC-AMED 2022 Dementia Collaborative Research Scheme funding commencing in 2022
Internal Reference ID:
2023/GNT2022961
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Baker Heart and Diabetes Institute
Recipient ABN:
98 131 762 948
Grant Recipient Location
Suburb:
Melbourne
Town/City:
Melbourne
Postcode:
3004
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA